An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia

This study aimed to assess the efficacy and tolerability of atorvastatin in Tanner stage (TS) 1 patients ages 6 to 10 years and TS ≥2 patients ages 10 to <18 years with genetically confirmed heterozygous familial hypercholesterolemia (HeFH) and a low density lipoprotein cholesterol (LDL-C) level...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandelman, Kuan, Glue, Paul, Laskey, Rachel, Jones, Jonathan, LaBadie, Robert, Ose, Leiv
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061213/
https://www.ncbi.nlm.nih.gov/pubmed/21259004
http://dx.doi.org/10.1007/s00246-011-9885-z